Immuron (IMRN) Interest Expenses (2016 - 2024)

Immuron's (IMRN) quarterly Interest Expenses came in at -$2.6 billion in Q4 2024, down 100806411.27% year-on-year from N/an in Q1 2024, and down 100806411.27% quarter-over-quarter from -$2608.5 in Q4 2023.

Immuron (IMRN) Interest Expenses (2016 - 2024) Analysis & Trends

Immuron's Interest Expenses history runs 9 years deep, the most recent figure standing at -$2.6 billion for Q4 2024.

  • On a quarterly basis, Interest Expenses fell 100806411.27% year-over-year to -$2.6 billion in Q4 2024; TTM through Sep 2025 was -$2.6 billion, a 100806411.27% decrease from a year earlier, with the FY2025 full-year figure at -$7305.0, up 3.58% from the prior year.
  • Interest Expenses fell to -$2.6 billion in Q4 2024 per IMRN's latest filing, from -$2608.5 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1126.9 in Q2 2023 and bottomed at -$2.6 billion in Q4 2024.
  • The 5-year median for Interest Expenses is -$3554.8 (2022), against an average of -$438.3 million.
  • Across the five-year window, Interest Expenses soared 99.78% in 2021 and plunged 100806411.27% in 2024, its largest moves.
  • Year by year, Interest Expenses stood at -$27500.0 in 2020, then surged by 99.78% to -$61.49 in 2021, then plunged by 7219.95% to -$4501.0 in 2022, then jumped by 42.05% to -$2608.5 in 2023, then plunged by 100806411.27% to -$2.6 billion in 2024.
  • Per Business Quant, the three latest IMRN Interest Expenses figures stand at -$2.6 billion (Q4 2024), -$2608.5 (Q4 2023), and $1126.9 (Q2 2023).
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Immuron 255.19 Mn 243.53 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.63 Bn
Dec 31, 2024 -2.63 Bn
Dec 31, 2023 -2,608.52
Dec 31, 2023 -2,608.52
Jun 30, 2023 1,126.86
Jun 30, 2023 1,126.86
Dec 31, 2022 -4,501.00
Dec 31, 2022 -4,501.00
Dec 31, 2021 -61.49
Dec 31, 2021 -61.49
Dec 31, 2020 -27,500.00
Dec 31, 2020 -27,500.00
Dec 31, 2019 -20,501.00
Dec 31, 2019 -20,501.00
Dec 31, 2018 -198,652.00
Dec 31, 2018 -198,652.00
Dec 31, 2017 -2,935.78
Dec 31, 2017 -2,935.78
Dec 31, 2016 41,133.27
Dec 31, 2016 41,133.27